agilon health (NYSE:AGL) Stock Price Up 8.7% – Still a Buy?

Shares of agilon health, inc. (NYSE:AGL) were up 8.7% on Monday . The company traded as high as $2.00 and last traded at $2.00. Approximately 1,453,440 shares traded hands during trading, a decline of 71% from the average daily volume of 4,929,089 shares. The stock had previously closed at $1.84.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on AGL. Royal Bank of Canada reiterated an “outperform” rating and set a $8.00 price target on shares of agilon health in a research note on Wednesday, August 7th. Citigroup reiterated a “sell” rating and set a $2.50 target price (down previously from $7.00) on shares of agilon health in a research report on Tuesday, October 29th. Evercore ISI decreased their target price on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research report on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft cut their price target on agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. Finally, Benchmark reissued a “buy” rating and issued a $9.00 price objective on shares of agilon health in a report on Thursday, August 8th. Three analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $7.34.

agilon health Price Performance

The company has a debt-to-equity ratio of 0.04, a current ratio of 1.36 and a quick ratio of 1.36. The company has a 50 day moving average price of $3.26 and a 200 day moving average price of $4.97. The firm has a market cap of $872.67 million, a PE ratio of -2.17 and a beta of 0.60.

Insider Transactions at agilon health

In other agilon health news, CEO Steven Sell acquired 20,000 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The shares were purchased at an average price of $3.36 per share, with a total value of $67,200.00. Following the completion of the acquisition, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. The trade was a 0.00 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Company insiders own 3.20% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. J.Safra Asset Management Corp grew its holdings in agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after purchasing an additional 3,625 shares during the last quarter. City State Bank acquired a new stake in agilon health in the third quarter valued at $52,000. CWM LLC grew its holdings in agilon health by 406.5% in the second quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after purchasing an additional 7,288 shares during the last quarter. Nisa Investment Advisors LLC acquired a new stake in agilon health in the second quarter valued at $60,000. Finally, Bleakley Financial Group LLC acquired a new stake in agilon health in the first quarter valued at $65,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.